AWM
ASND icon

Avior Wealth Management’s Ascendis Pharma A/S ASND Stock Holding History

Avior Wealth Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,463
Closed -$1.25M – 793
2026
Q1 		$1.25M Sell
5,463
-1,042
-16% -$234K 0.04% 310
2025
Q4 		$1.39M Sell
6,505
-1,056
-14% -$218K 0.04% 255
2025
Q3 		$1.5M Hold
7,561
– – 0.05% 230
2025
Q2 		$1.31M Hold
7,561
– – 0.05% 241
2025
Q1 		$1.18M Hold
7,561
– – 0.04% 240
2024
Q4 		$1.04M Sell
7,561
-651
-8% -$85.6K 0.04% 279
2024
Q3 		$1.23M Buy
8,212
+240
+3% +$32.4K 0.05% 248
2024
Q2 		$1.09M Buy
7,972
+150
+2% +$20.4K 0.05% 255
2024
Q1 		$1.18M Hold
7,822
– – 0.05% 250
2023
Q4 		$985K Buy
7,822
+645
+9% +$64.3K 0.06% 210
2023
Q3 		$672K Buy
7,177
+814
+13% +$76.2K 0.05% 264
2023
Q2 		$568K Buy
6,363
+547
+9% +$47.6K 0.04% 307
2023
Q1 		$624K Buy
5,816
+287
+5% +$32.8K 0.04% 284
2022
Q4 		$675K Buy
5,529
+136
+3% +$15.8K 0.05% 240
2022
Q3 		$556K Buy
5,393
+24
+0.4% +$2.27K 0.05% 249
2022
Q2 		$499K Hold
5,369
– – 0.05% 252
2022
Q1 		$630K Sell
5,369
-882
-14% -$102K 0.05% 241
2021
Q4 		$840K Buy
6,251
+1,447
+30% +$215K 0.07% 227
2021
Q3 		$765K Hold
4,804
– – 0.06% 230
2021
Q2 		$631K Buy
4,804
+529
+12% +$70.5K 0.06% 251
2021
Q1 		$550K Buy
4,275
+1,008
+31% +$153K 0.06% 278
2020
Q4 		$544K Buy
3,267
+557
+21% +$92.1K 0.07% 247
2020
Q3 		$418K Buy
2,710
+170
+7% +$24.4K 0.06% 271
2020
Q2 		$375K Buy
2,540
+720
+40% +$98.9K 0.06% 292
2020
Q1 		$204K Buy
+1,820
New +$236K 0.04% 342

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Avior Wealth Management's ASND Position: Q2 2026 in Review

Avior Wealth Management sold out of Ascendis Pharma A/S (ASND) in Q2 2026, closing a stake of 5,463 shares — an estimated $1.25M sold.

Avior Wealth Management first reported a position in ASND in Q1 2020 and held it in 25 quarters. The position peaked at $1.5M in Q3 2025. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Avior Wealth Management reported no remaining Ascendis Pharma A/S position as of Q2 2026 after selling out during the quarter.
  • Avior Wealth Management sold 5,463 Ascendis Pharma A/S shares in Q2 2026, an estimated $1.25M.
  • Avior Wealth Management first reported a position in Ascendis Pharma A/S in Q1 2020 and held it in 25 quarters.
  • Avior Wealth Management's Ascendis Pharma A/S position peaked at $1.5M in Q3 2025.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.